Table 1.
Estimates of condom effectiveness.
Table 2.
Description of scenarios used in condom investment case.
Table 3.
Annual coital frequency assumptions among risk groups used to estimate condom use.
Fig 1.
Global current use and need for condoms for family planning and STI/HIV prevention, 2015 (billions), 81 countries.
Table 4.
Global estimates of current use, need, and gap in condoms for family planning, by region, 2015 (millions).
Table 5.
Global estimates of current use, need, and gap in condoms for HIV and STI prevention, among risk groups (2015) in millions of condoms.
Table 6.
Total cost of condoms for FP and HIV/STI prevention, by scenario, in billions $US, 2015–2030, 81 countries.
Table 7.
Incremental cost of condoms for FP and HIV/STI prevention, in millions, US$, 2015–2020, 2015–30, total and by region.
Table 8.
Condom effectiveness: Births averted and DALYs averted, by region (2015–2030).
Table 9.
Condom effectiveness: HIV infections and DALYs averted, by region (2015–2030).
Table 10.
Condom effectiveness: STI infections and DALYs averted, by region (2015–2030), medium and high scenarios.
Table 11.
Incremental cost, effectiveness, and cost-effectiveness ratio of condoms, (2015–2030).
Table 12.
Condom cost-effectiveness, on average for all condom investment framework countries, 2015–2030.
Table 13.
Range of ICERs resulting from the sensitivity analysis, medium and high scenarios, 2015–2030.
Fig 2.
Cost-effectiveness of various HIV/STI/FP interventions, cost per DALY averted, $US 2015.